Literature DB >> 27513229

Evaluation of tetanus antibody levels in adults in Yozgat, Turkey.

Çiğdem Kader1, Mehmet Balci2, Ayşe Erbay1.   

Abstract

BACKGROUND/AIM: To assess the immune status against tetanus in relation to self-declared vaccination status among an adult population in Yozgat, Turkey.
METHODS: Questionnaires and blood specimens were collected from 267 individuals over 18 years of age in Yozgat, Turkey. Antitetanus antibodies were determined quantitatively by enzyme-linked immunosorbent assay.
RESULTS: Among the 267 subjects (mean age 43.4 ± 15.6; male:female, 133:134) 168 (62.9%) had protective level of tetanus antibody titers. There was a characteristic distribution of the tetanus antibody titers in different age groups as it dropped with increasing age. Protective immunity was obtained in 74.1% of urban and 47.9% of rural participants. The lowest immunity was observed among farmers (53.3%) and housewives (55.6%) when compared to other occupations. Protective antibody titers were detected in 25% of the individuals who had not finished any school, while the rate was 83.7% in those who had graduated from university. While the protection rate in women who had been vaccinated during pregnancy was 78.3%, this rate was 39.2% in nonvaccinated women.
CONCLUSION: Our findings confirm that only 62.9% of the population is immunized against tetanus, with a lack of coverage in particular for the elderly and in rural areas. It is necessary to follow the recommendations for 10-year boosters for tetanus.

Entities:  

Keywords:  Tetanus; Turkey; Yozgat; immunity

Mesh:

Substances:

Year:  2016        PMID: 27513229     DOI: 10.3906/sag-1503-38

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  1 in total

1.  Tetanus immunity status among adult trauma patients in an ED.

Authors:  Ibrahim Toker; Turgay Yılmaz Kılıc; Sukran Kose; Murat Yesilaras; Feriyde Calıskan; Ozge Duman Atilla; Orkun Unek; Serkan Hacar; Aysin Kılınc Toker
Journal:  Turk J Emerg Med       Date:  2017-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.